|
1
|
Singal AG and El-Serag HB: Hepatocellular
carcinoma from epidemiology to prevention: Translating knowledge
into practice. Clin Gastroenterol Hepatol. 13:2140–2151. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fan ST, Mau Lo C, Poon RT, Yeung C, Leung
Liu C, Yuen WK, Ming Lam C, Ng KK and Ching Chan S: Continuous
improvement of survival outcomes of resection of hepatocellular
carcinoma: A 20-year experience. Ann Surg. 253:745–758. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shi Y, Yang X, Xue X, Sun D, Cai P, Song
Q, Zhang B and Qin L: HANR enhances autophagy-associated sorafenib
resistance through miR-29b/ATG9A axis in hepatocellular carcinoma.
Onco Targets Ther. 13:2127–2137. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo Y, Bai M, Lin L, Huang J, An Y, Liang
L, Liu Y and Huang W: LncRNA DLEU2 aggravates the progression of
hepatocellular carcinoma through binding to EZH2. Biomed
Pharmacother. 118:1092722019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu Z, Chen JY, Zhong Y, Xie L and Li JS:
lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells
by sponging miR-9-5p to upregulate SOX11. Braz J Med Biol Res.
52:e86312019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang X, Sun L, Wang L, Yao B, Mo H and
Yang W: LncRNA SNHG7 accelerates the proliferation, migration and
invasion of hepatocellular carcinoma cells via regulating
miR-122-5p and RPL4. Biomed Pharmacother. 118:1093862019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gu M, Zheng W, Zhang M, Dong X, Zhao Y,
Wang S, Jiang H and Zheng X: LncRNA NONHSAT141924 promotes
paclitaxel chemotherapy resistance through p-CREB/Bcl-2 apoptosis
signaling pathway in breast cancer. J Cancer. 11:3645–3654. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Zhao B, Chen X, Wang Z, Xu H and
Huang B: Silence of long noncoding RNA NEAT1 inhibits malignant
biological behaviors and chemotherapy resistance in gastric cancer.
Pathol Oncol Res. 24:109–113. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J, Zhou M, Zhao X, Wang G and Li J:
Long noncoding RNA LINC00173 is downregulated in cervical cancer
and inhibits cell proliferation and invasion by modulating the
miR-182-5p/FBXW7 axis. Pathol Res Pract. 216:1529942020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fan H, Yuan J and Li X, Ma Y, Wang X, Xu B
and Li X: LncRNA LINC00173 enhances triple-negative breast cancer
progression by suppressing miR-490-3p expression. Biomed
Pharmacother. 125:1099872020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang F, Lei P, Zeng W, Gao J and Wu N:
Long noncoding RNA LINC00173 promotes the malignancy of melanoma by
promoting the expression of IRS4 through competitive binding to
microRNA-493. Cancer Manag Res. 12:3131–3144. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiao F, Li Y, Wan Y and Xue M:
MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based
chemotherapy through regulation of ATP7A/B. Cancer Chemother
Pharmacol. 81:935–947. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Niu YC, Tong J, Shi XF and Zhang T:
MicroRNA-654-3p enhances cisplatin sensitivity by targeting QPRT
and inhibiting the PI3K/AKT signaling pathway in ovarian cancer
cells. Exp Ther Med. 20:1467–1479. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang S, Wang P, Wang S, Cong A, Zhang Q,
Shen W, Li X, Zhang W and Han G: miRNA-181a-5p enhances the
sensitivity of cells to cisplatin in esophageal adenocarcinoma by
targeting CBLB. Cancer Manag Res. 12:4981–4990. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao Y, Zheng R, Chen J and Ning D:
CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes
to cisplatin resistance in non-small cell lung cancer (NSCLC).
Cancer Cell Int. 20:2892020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Persijn van Meerten EL, Gelderblom H
and Bloem JL: RECIST revised: Implications for the radiologist. A
review article on the modified RECIST guideline. Eur Radiol.
20:1456–1467. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang SY, Wang X and Zhang CY: LncRNA SNHG7
enhances chemoresistance in neuroblastoma through cisplatin-induced
autophagy by regulating miR-329-3p/MYO10 axis. Eur Rev Med
Pharmacol Sci. 24:3805–3817. 2020.PubMed/NCBI
|
|
21
|
Xu Q, Lin YB, Li L and Liu J: LncRNA
TLR8-AS1 promotes metastasis and chemoresistance of ovarian cancer
through enhancing TLR8 mRNA stability. Biochem Biophys Res Commun.
526:857–864. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu Y, Lu X, Yang C and Yin F: Long
noncoding RNA LINC00173 contributes to the growth, invasiveness and
chemo-resistance of colorectal cancer through regulating
miR-765/PLP2 axis. Cancer Manag Res. 12:3363–3369. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zeng F, Wang Q, Wang S, Liang S, Huang W,
Guo Y, Peng J, Li M, Zhu W and Guo L: Linc00173 promotes
chemoresistance and progression of small cell lung cancer by
sponging miR-218 to regulate Etk expression. Oncogene. 39:293–307.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Hou J, He D, Sun M, Zhang P, Yu Y
and Chen Y: The emerging function and mechanism of ceRNAs in
cancer. Trends Genet. 32:211–224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou J, Li H, Li N, Li X, Zhang H, Song Q
and Peng M: MicroRNA-641 inhibits lung cancer cells proliferation,
metastasis but promotes apoptosis in cells by targeting PDCD4. Int
J Clin Exp Pathol. 10:8211–8221. 2017.PubMed/NCBI
|
|
27
|
Yao R, Zheng H, Wu L and Cai P: miRNA-641
inhibits the proliferation, migration, and invasion and induces
apoptosis of cervical cancer cells by directly targeting ZEB1. Onco
Targets Ther. 11:8965–8976. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang J, Liang B and Hou S: TMPO-AS1
promotes cervical cancer progression by upregulating RAB14 via
sponging miR-577. J Gene Med. 21:e31252019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo B, Wang W, Zhao Z, Li Q, Zhou K, Zhao
L, Wang L, Yang J and Huang C: Rab14 Act as oncogene and induce
proliferation of gastric cancer cells via AKT signaling pathway.
PLoS One. 12:e01706202017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhai Y, Liu M and Zheng Y: MicroRNA-451
dictates the anoikis resistance of osteosarcoma by targeting Rab14.
Int J Clin Exp Pathol. 10:10989–10997. 2017.PubMed/NCBI
|
|
31
|
Ge J and Ge C: Rab14 overexpression
regulates gemcitabine sensitivity through regulation of Bcl-2 and
mitochondrial function in pancreatic cancer. Virchows Arch.
474:59–69. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim EA, Kim TG, Sung EG, Song IH, Kim JY,
Doh KO and Lee TJ: miR-148a increases the sensitivity to cisplatin
by targeting Rab14 in renal cancer cells. Int J Oncol. 50:984–992.
2017. View Article : Google Scholar : PubMed/NCBI
|
